Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
more
I am looking for
added new label for I am looking for
more
Advanced Filters
Found 76 clinical trials
Stop Hep B @ Birth

hepatitis B virus: antenatal tenofovir, and timely newborn administration of hepatitis B birth dose vaccine and hepatitis B immune globulin; Component II aims to achieve high coverage of screening

cirrhosis
tenofovir
encephalopathy
fumarate
mother-to-child transmission
  • 0 views
  • 15 Aug, 2021
  • 1 location
PrEP Affect Regulation Treatment Innovation (PARTI)

directly observed PrEP doses (PARTI+CM) compared to an attention-control condition delivered during CM. The primary outcome is HIV acquisition risk measured using a combination of tenofovir-diphosphate

Accepts healthy volunteers
  • 0 views
  • 27 May, 2022
  • 2 locations
Chronic Hepatitis b Patients Switch to tAf After Discontinuation of Nucleoside Analogue

We will conduct a phase 4, multicenter, open-label trial at 7 academic centers in Taiwan. Chronic hepatitis B patients receiving oral antiviral therapy (entecavir [ETV], tenofovir

antiviral therapy
fumarate
tenofovir
hepatitis
entecavir
  • 0 views
  • 12 Aug, 2021
  • 7 locations
Same-Day PrEP Initiation and Sexual Health for Transgender Women

emtricitabine/tenofovir alafenamide (F/TAF), a new PrEP regimen, has not to our knowledge previously been evaluated as PrEP in African trans women. F/TAF is potentially more efficacious and safer than

HIV Vaccine
pre-exposure prophylaxis (prep)
emtricitabine/ tenofovir disoproxil fumarate
drug level
tenofovir
  • 0 views
  • 16 Dec, 2021
  • 1 location
Three Types of Nucleotide/Nucleoside Analogues Therapy in Patients With Chronic Hepatitis b

This study is to investigate the clinical efficacy and safety of three types of nucleotide/nucleoside analogues in treatment of chronic hepatitis b

chronic hepatitis
tenofovir
entecavir
hepatitis b antigen
fumarate
  • 0 views
  • 21 Feb, 2022
  • 1 location
Three Types of Nucleotide/Nucleoside Analogues Therapy in Patients With Hepatitis b Virus Related Compensated Cirrhosis

This study is to investigate the clinical efficacy and safety of three types of nucleotide/nucleoside analogues in treatment of hepatitis b virus related compensated cirrhosis.

cirrhosis
fumarate
hepatitis
tenofovir
entecavir
  • 0 views
  • 21 Feb, 2022
  • 1 location
Three Types of Nucleotide/Nucleoside Analogues Treatment in HBV Related ACLF (HBV)

This study is to investigate the clinical efficacy of three types of nucleotide/nucleoside analogues in treatment of HBV-related acute-on-chronic liver failure.

hepatic failure
serum total bilirubin level
prothrombin
tenofovir
entecavir
  • 3 views
  • 03 Feb, 2022
  • 1 location
Dolutegravir-Lamivudine for naïve HIV-Infected Patients With ≤200 CD4/mm3 (DOLCE)

Protocol Title: DOLCE: Dolutegravir-Lamivudine for naïve HIV-Infected Patients with ≤200 CD4/mm3 Protocol Number: FH-57 Study Objectives: To assess the antiviral activity at week 48 of DTG+3TC among naïve HIV patients with a CD4 count ≤200 cells /mm3.

  • 1 views
  • 09 Apr, 2023
  • 4 locations
Pre-exposure Prophylaxis (PrEP) at Home (PrEP@Home)

This study is a randomized clinical trial of PrEP@Home, a home care system for Human Immunodeficiency Virus (HIV) Pre-Exposure Prophylaxis (PrEP). Individuals entering into PrEP care at an initial in-person study visit will be randomized to the PrEP@Home system for home-based PrEP care follow-up visits or to the control standard …

pre-exposure prophylaxis (prep)
immunodeficiency
HIV Infection
Accepts healthy volunteers
AIDS prevention
  • 31 views
  • 04 Oct, 2022
  • 4 locations
Adherence and Clinical Correlates in Persons With HIV on TAF (ACT)

gold-standard measure to monitor ARV exposure and adherence that has been implemented in clinical practice. Tenofovir diphosphate (TFV-DP), the phosphorylated anabolite of tenofovir (TFV), has distinct

  • 0 views
  • 04 Oct, 2022
  • 1 location